Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Rifagut 550 Tablet

Rifagut 550 Tablet is a prescription antibiotic containing Rifaximin 550 mg, used to treat traveler's diarrhoea caused by E.coli, hepatic encephalopathy, and irritable bowel syndrome with diarrhoea (IBS-D). It is a gut-selective, broad-spectrum antimicrobial that helps relieve abdominal pain and control diarrhoea by inhibiting bacterial growth in the intestines.

₹459.20
In stock
SKU
SBRI06790
Price: 410.00 (Inclusive of 12% GST)
- +
Rifagut 550 Tablet is available to buy in increments of 1

Contact us for sales assistance from our Biomedical Engineer.

Prashanth Reddy V | Senior Sales Executive

+91 9063507429

[email protected]

Features:

  • Contains Rifaximin 550 mg – a non-absorbable antibiotic

  • Broad-spectrum activity – effective against gram-positive, gram-negative, aerobic, and anaerobic gut bacteria

  • Gastrointestinal selective – minimal systemic absorption

  • Reduces ammonia-producing bacteria – helpful in hepatic encephalopathy

  • Alleviates symptoms of IBS-D

  • Low resistance development risk due to gut-selective action

Technical Details
Technical Specification
  • Brand Name: Rifagut 550

  • Composition: Rifaximin 550 mg

  • Dosage Form: Oral Tablet

  • Therapeutic Class: Gastrointestinal antibiotics

  • Prescription Required: Yes

  • Route of Administration: Oral

  • Manufacturer: Sun Pharmaceutical Industries Ltd

  • Storage: Store below 25°C, protect from light and moisture

  • 1 Strip of 10 Tablets
  • Treats traveller’s diarrhoea caused by non-invasive E. coli

  • Manages hepatic encephalopathy by reducing gut-derived neurotoxins

  • Reduces symptoms of IBS-D such as bloating, gas, and loose stools

  • Minimally absorbed – safe for long-term gut-targeted therapy

  • Bactericidal mechanism – kills bacteria rather than just inhibiting them

  • Lower systemic side effects due to localised gut action

Your Practice might also need
Copyright © 2023-present SignelbioMedical, Inc. All rights reserved.